Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromes:

Sotirios Papageorgiou,Ioannis Kotsianidis,Anthi Bouchla,A. Symeonidis,Athanasios Galanopoulos,Nora-Athina Viniou,Eleftheria Hatzimichael,Theodoros P. Vassilakopoulos,Dimitrios Gogos,Aikaterini Megalakaki,Panagiotis Zikos,Panagiotis T. Diamantopoulos,Alexandra Kourakli,Panagiota Giannoulia,Menelaos Papoutselis,Elias Poulakidas,Maria Arapaki,Anna Vardi,Achilles Anagnostopoulos,Despoina Mparmparousi,Maria Papaioannou,Eleni Bouronikou,Maria Dimou,Helen A. Papadaki,Panayiotis Panayiotidis,Vasiliki Pappa

Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromes:

2020

Background:5-azacytidine (5-AZA) improves survival of patients with higher-risk myelodysplastic syndromes (MDSs) and oligoblastic acute myeloid leukemia (AML); however, predictive factors for respo...

Keywords:

in patient
ECOG Performance Status
Myeloid leukemia
national registry
serum ferritin
Oncology
Internal medicine
Medicine
Myelodysplastic syndromes
retrospective analysis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations